| Tag | Content |
|---|
EnhancerAtlas ID | HS019-11557 |
Organism | Homo sapiens |
Tissue/cell | CD20+ |
Coordinate | chr3:58007950-58010000 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Gabpa | MA0062.2 | chr3:58009918-58009929 | GCCACTTCCGG | - | 6.62 | | HES2 | MA0616.2 | chr3:58008967-58008977 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr3:58008967-58008977 | GGCACGTGCC | - | 6.02 | | Nr2f6(var.2) | MA0728.1 | chr3:58009028-58009043 | TGAACTCCTGACCTC | - | 6.22 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_41579 | chr3:58009601-58010418 | LNCaP | | SE_47269 | chr3:58008943-58010522 | Panc1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH03I058018 | chr3 | 58004531 | 58008254 | | GH03I058023 | chr3 | 58008944 | 58010522 |
|
Enhancer Sequence | TAAATAAACA GTCTCTAGTA TAATAGCTTG AGTATTAAGA CTGGTACATT GACTTATTTG 60
CAATTCAGAA AATGCAAAAC AGTGGTTCTT TGCTGCCTTT AGTGAAGTGG GAATTATATG 120
TAGTAGACAA CTGGGTCTGG GGTCCCAGTG GAACACTTCG TTTTTGGACT GTGATGCTGA 180
ACTTAAAGAA CTCAGCAGTT CATGTTCATT CTCTGGACAT CTGTGATTTG CTTCAACAAC 240
TGTTAGAGAA CAAGGCCTTT TCCAGGTGAA GCTCAGAAAA TGAATTTAAT AGGAAATTAC 300
TGAAAGTCAC AATCATAGTA ACAGTTTCAT TAGTTACAGT GAATATAGAG AGAGCCCATA 360
CAAAGTACCA GGCATTGTGA TAAACGCTTC TTACTAATAG CTATACAAAA CATCATTGCA 420
ATTCTGAGAA GTAGTTATTG TTGTAATTCC CGTTATGCAG ATGAGAAAAC TGAGGCACAC 480
CCAGATTGGC CAGTGAGTGT GTGGTTATTA CTCAGATTCT TGTCTGAGAT TTTAATCTTC 540
ATATTTTACT GCTTTCCCAA GGAAAGCCAT CAGCTCAGCA AGTCTTTGAA ATTTGCTTCT 600
TTTTTTTTTT TTGAGACAGA GTCTTGCTGT GTCTCCCAGG CTGGAGTACA GTGGCGCAAT 660
CTTGGCTCAC TGCAACCTCC GCCTCCTGGG TTCAAGCGAT TCTCTTGCCT CAGCCTCCCG 720
AGTAGCTGGG AATATAGTTG CATGCCACCA CACCTGGCTA TTTTGTATTT TTAGTAGAGA 780
CGGGGTTTCA CCATGTTGGC CAGCCTGGTC CTGAACTCCT GATCTCGAGA TCCACCTGCC 840
TCGGCCTCCT AAAGTGCTGG GATCAGGCTT GAGCCACCGA ACTCGGCCTT TTTTTTTTTT 900
TTTTTTGAAA TGATGTCTCC TTTTGTTGCC CAAACTGCAG TCTTGGCTCA CTGCAACTTC 960
TGCCTCCTGG GTTCAAGTGA TTCTCCTGCC TCAGCCTCCC GAGTAGCTGG GACTACAGGC 1020
ACGTGCCACC ATGCCCAGCT AATTTTTGTA TTTTTATAGA GACAGGCTAA GCTTGTCTTG 1080
AACTCCTGAC CTCAAGTGAT CCACCTACCT GGCCCTCCCA AAGTGCTGGG ATTACAGGAG 1140
TGAGCCCCTG TGCCCAGCCT GAAATTCAAT TCTAATAAAT TTTTATTGGA GCATTAAAAA 1200
GTTACATCTG TAGTTGTTAC TCTTTGCAAA AAATTGCAAG AACACAGAAA AATATAAAGA 1260
AAAAAATCAC CTGTGAAGAA TTTTAATGAA TCTTTTTCTA CTTTTAGGGG ATTTTGCTTA 1320
CAGCTGCCTT TTAATCAGAA TAGGGAAGAA AGAGATTCCT TTCTCAGGAA AAAAGTGACT 1380
GTGGACTGGA AATGCTTTGT GAAATAATTT TGGTCATACT GATGGTTATA ACAAGATTCG 1440
TCTTCAATTG AGTTATTGCT GAGCTTTGTC CAACATTAAA ATGAAAGGTC TCATTTGAGT 1500
CTCATTGTGG TTTGCAAGTC TCCCTTGGTC TAGAAATATG TTTGGTCAAC CACGGCATGG 1560
AGGTGTTCCA GCCACTTTCT GTCTCTTAAA AGTTTTTAGG ACCTACTTTT ATTGGGACTG 1620
CCAGGGTCTC TTAATAATAG TTATTATACT TGGTAACTAT TGTGACCTTG TCTCATAGGC 1680
AGCCCAGCAT AGAAACTCAT TTAGCTTTTA GTTGCTCAGC TCCATTAGCT GTTTAAACAT 1740
GTTTCAGATG TGAGCCTGAC AATGTACTTG GGCAGCTTGG TTCACCCTTG ACTGCCTGGG 1800
AACTTTGAGA AGTCTGAAAA TTATATGTAG CCCTAAGGTC TTCATGGTAT TGTTTTTTTG 1860
GAGGCACCAT TTCCCAATAG CCCTGAGGAC ACCAGGCCCA TGAAGCCATC CTGTCTCAGC 1920
CAGGAGGCAG AGGAGATGGA ATGGAAACCA CTTCTGGATA CAGATCCAGC CACTTCCGGA 1980
GTGCTTCAGA GCATGGGTCA GATAGACCTT GCTGCTTTCT AGCTGGCAGA CTTGGGGAAG 2040
GTTGTTTGAC 2050
|
